Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
NCT02441907
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
aflibercept
Sponsor
Unity Health Toronto